Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
interpretation for patient stratification, discovery of biomarkers for disease risks, diagnosis, drug response and monitoring of health. Precision medicine research is expected to make use of existing strong
-
also works closely with other colleagues involved in animal work, fluid-based biomarker discovery and the conducting of clinical trials. Essential to this role is the ability to generate, maintain and
-
of clinical research studies. Provide mentorship to junior researchers and oversee lab operations. Collaborate with faculty on projects involving biomarkers, digital health platforms, and neuroinformatics
-
Computational Imaging Research Lab (CIR), Department of Biomedical Imaging and Image-guided Therapy | Austria | 3 months ago
treatment-response prediction, and (3) build a multimodal Visual Foundation Model for arthritis that boosts downstream tasks and enables discovery of new biomarkers and arthritis subtypes. Ultimately
-
treatment methods and identify biomarkers in patients with metastatic melanoma. Despite significant progress in recent decades, many patients do not respond to current treatments or experience relapse. By
-
develop and optimize cell therapy approaches for use as immunotherapeutics in induction and maintenance of tolerance as well as identify, test, and validate biomarkers in various disease models
-
proteomic and transcriptomic approaches, for the identification of novel biomarkers and mechanisms of development and disease. We collaborate with outstanding labs in the field of bioengineering
-
associated events that may serve as both therapeutic targets and biomarkers for early onset dementia such as early onset Alzheimer’s disease and frontotemporal dementia. Our research leverages comprehensive
-
Neuron Disease and Frontotemporal Dementia, and advance biomarker discovery. Your key responsibilities will be to: contribute to the design and development of research protocols, ensuring timely execution
-
. Our lab is focused on overcoming chemotherapy resistance in gynecologic cancers by targeting DNA damage repair mechanisms. We specifically are interested in developing novel biomarkers and therapies